Risk factors of alcohol problem drinking among female bar/hotel workers in Moshi, Tanzania: a multi-level analysis. by Ao, Trong Thanh-Hoang et al.
Kapiga, SH; Ewings, FM; Ao, T; Chilongani, J; Mongi, A; Baisley, K;
Francis, S; Andreasen, A; Hashim, R; Watson-Jones, D; Changalucha,
J; Hayes, R (2013) The Epidemiology of HIV and HSV-2 Infections
among Women Participating in Microbicide and Vaccine Feasibility
Studies in Northern Tanzania. PLoS One, 8 (7). e68825. ISSN 1932-
6203
Downloaded from: http://researchonline.lshtm.ac.uk/1082619/
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: Creative Commons Attribution http://creativecommons.org/licenses/by/2.5/
The Epidemiology of HIV and HSV-2 Infections among
Women Participating in Microbicide and Vaccine
Feasibility Studies in Northern Tanzania
Saidi H. Kapiga1,2*., Fiona M. Ewings1,2., Tony Ao2, Joseph Chilongani3, Aika Mongi2, Kathy Baisley1,
Suzanna Francis1, Aura Andreasen1,2, Ramadhan Hashim2, Deborah Watson-Jones1,2,
John Changalucha3, Richard Hayes1
1 London School of Hygiene and Tropical Medicine, London, United Kingdom, 2Mwanza Intervention Trials Unit, Mwanza, Tanzania, 3National Institute for Medical
Research, Mwanza, Tanzania
Abstract
Objectives: To prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in
food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and
associated risk factors.
Methods: Women aged 18–44 years working in food and recreational facilities were screened to determine their eligibility
for the studies. Between 2008–2010, HIV-negative women were enrolled and followed for 12 months. At enrolment and 3-
monthly, we collected socio-demographic and behavioural data, and performed clinical examinations for collection of
biological specimens that were tested for reproductive tract infections. Risk factors for HIV and HSV-2 incidence were
investigated using Poisson regression models.
Results: We screened 2,229 and enrolled 1,378 women. The median age was 27 years (interquartile range, IQR 22, 33), and
median duration working at current facility was 2 years. The prevalences of HIV at screening and HSV-2 at enrolment were
16% and 67%, respectively. Attendance at the 12-month visit was 86%. HIV and HSV-2 incidence rates were 3.7 (95%
confidence interval, CI: 2.8,5.1) and 28.6 (95% CI: 23.5,35.0)/100 person-years, respectively. Women who were separated,
divorced, or widowed were at increased risk of HIV (adjusted incidence rate ratio, aRR = 6.63; 95% CI: 1.97,22.2) and HSV-2
(aRR = 2.00; 95% CI: 1.15,3.47) compared with married women. Women reporting $3 partners in the past 3 months were at
higher HIV risk compared with women with 0–1 partner (aRR = 4.75; 95% CI: 2.10,10.8), while those who had reached
secondary education or above were at lower risk of HSV-2 compared with women with incomplete primary education
(aRR = 0.42; 95% CI: 0.22,0.82).
Conclusions: HIV and HSV-2 rates remain substantially higher in this cohort than in the general population, indicating
urgent need for effective interventions. These studies demonstrate the feasibility of conducting trials to test new
interventions in this highly-mobile population.
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Introduction
HIV infection remains a major public health problem despite
evidence of declining incidence in many parts of the world and
increasing access to antiretroviral therapy. Tanzania is one of the
countries within sub-Saharan Africa severely affected by the HIV
epidemic, with an estimated 1.5 million people living with HIV at
the end of 2010 [1]. Based on national surveys, the prevalence of
HIV among the general adult population was estimated to be
7.0% in 2003–4 [2] and 5.7% in 2007–8 [3].
In Tanzania, HIV prevalence is generally higher among women
than men [2,3], indicating that the impact of the epidemic is not
uniform. In particular, women working in hotels, restaurants, bars
and other food and recreational facilities have substantially higher
HIV prevalence and incidence than women in the general adult
population [4–7]. Although several factors have been postulated to
account for the increased HIV vulnerability among these women,
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including being involved in complex sexual networks with multiple
partners and exchange of sex for gifts or money, more studies are
needed to investigate new strategies to help reduce the burden of
HIV in this population.
Most current HIV prevention methods require the consent (as
well as some action or behaviour change) of the male partner.
Correct and consistent use of latex condoms is one proven method
of preventing HIV transmission; however, condoms are widely
regarded as inadequate prevention options for women, because
many women are unable to negotiate condom use with their
partners [8]. Male circumcision is another proven HIV prevention
method but there is no evidence that this is effective in reducing
transmission from men to women [9]. Thus, the search for new
prevention methods, such as microbicides and vaccines, remains a
major global public health priority.
In order to prepare for future HIV prevention trials, we
conducted two prospective cohort studies among women working
in hotels, restaurants, bars and other food and recreational
facilities in northern Tanzania. The objectives were to assess
feasibility, retention and appropriateness of this population for
future trials. In this report, we describe the prevalence and
incidence of HIV and herpes simplex virus type 2 (HSV-2), and
examine their risk factors. We examined risk factors for HSV-2, in
addition to HIV, because HSV-2 is a common sexually
transmitted infection (STI) known to be associated with increased
risk of HIV acquisition [10].
Methods
Ethics Statement
The studies were approved by the Ethics Committees of the
National Institute for Medical Research (NIMR), Kilimanjaro
Christian Medical Centre (KCMC), and London School of
Hygiene and Tropical Medicine. All participants received detailed
information about the study to ensure that they understood why
the study was being carried out, what the study involved and the
involvement of the three collaborating research institutions.
Furthermore, they were informed that participation in the study
was voluntary and written informed consent (signature or
witnessed thumbprint) was obtained prior to screening and
enrolment. Participants’ confidentiality was ensured by excluding
personal identification (such as names) from forms used to collect
study information and by storing study documents and samples in
a secure location. Study staff were trained on issues of
confidentiality, good clinical practice, research ethics and protec-
tion of human subjects. At the end of the study, participants were
invited to dissemination meetings where the main findings were
presented and discussed.
Study Populations and Recruitment
Between 2008–2010, we recruited women working in hotels,
restaurants, bars, guesthouses or shops selling traditionally-brewed
beer, or food-sellers at makeshift facilities (mamalishe) in the
northern Tanzanian towns of Geita, Kahama, Shinyanga (for
the microbicides-preparedness study) and Moshi (for the vaccines-
preparedness study). Three of these towns have large-scale gold
(Geita and Kahama) and diamond (Shinyanga) mines which
attract a large number of men seeking employment. Shinyanga,
Kahama and Moshi are also along major highways connecting
northern Tanzania with the capital city of Dar es Salaam and
other countries in the East African region, while Moshi, on the
slopes of Mount Kilimanjaro, is also a major destination for
international tourism and has a high number of hotels and
guesthouses. These factors may contribute to increased risk of HIV
among women residing in these towns.
In each town, we determined the number of facilities located in
each local ward, the governmental administrative unit responsible
for a defined geographical area. Enrolment began in the ward with
the largest number of facilities and progressed to the ward with the
next largest number of facilities until the study sample size was
reached. The target sample size was 1000 women for the
microbicides-preparedness cohort and 500 for the vaccines-
preparedness cohort. In each selected local administrative ward,
study staff met with local leaders, facility owners, facility managers,
and health officials to inform them about the study objectives
before commencing data collection. Women were eligible for
enrolment if they were aged 18–44 years, willing to undergo HIV
testing and to receive results, and not planning to move away for
the duration of the study. We enrolled HIV-negative women,
although some HIV-positive women were enrolled at the Moshi
site for a separate sub-study to investigate the molecular
epidemiology of HIV.
Study Procedures
In each participating food and recreational facility, we invited
all women employed at the facility to visit the study clinic located
within (for Shinyanga, Kahama and Moshi towns) or near (for
Geita town) an existing public hospital for more detailed
information about the study and an eligibility assessment as part
of the screening process. During the screening visit, women
underwent a brief interview to collect limited information about
demographic variables, behavioural risk factors for STIs and other
information to determine their study eligibility. HIV rapid testing
was performed, with pre- and post-test counselling, and blood
samples were collected for those with concordant positive or
discordant test results for confirmatory testing. However, in Moshi,
those determined ineligible for other reasons were not tested.
Women confirmed to be HIV-negative and fulfilling other
inclusion criteria were invited to come to an enrolment visit within
4 weeks. At enrolment, structured face-to-face interviews were
conducted to obtain information about socio-demographic char-
acteristics, employment, reproductive history, sexual behaviour
and work mobility. Information about alcohol use, including
screening for problem drinking, was obtained using CAGE [11]
and Alcohol Use Disorders Identification Test (AUDIT) [12]
questionnaires. Samples of 5–10 ml of whole blood were collected
for detection of syphilis, HSV-2 and HIV infections. A clinical
examination was performed and genital samples for detection of
other STIs and other genital infections were collected.
All women enrolled in the study were scheduled to return to the
clinic every three months for 12 months. During each visit, similar
interviews, clinical examinations and blood and genital sample
collection were performed as at enrolment.
Blood and genital samples were transported to either a
laboratory at NIMR in Mwanza city (microbicides-preparedness
cohort) or KCMC in Moshi (vaccines-preparedness cohort) for
further processing. Study participants with positive laboratory
results for curable STIs (Neisseria gonorrhoeae, Chlamydia trachomatis,
Trichomonas vaginalis or syphilis) or HIV were asked to return to the
research clinic as soon as possible for post-test counseling and
treatment as appropriate. Women with STI-related symptoms or
laboratory-confirmed infections at any time received treatment at
no cost, in accordance with the Tanzanian Ministry of Health
guidelines.
HIV and HSV-2 among Tanzanian Women at High Risk
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Laboratory Methods
Testing for infections was performed according to standard
operating procedures in each of the NIMR and KCMC
laboratories. At all sites, HIV rapid testing was performed at
screening in parallel using SD Bioline HIV-1/2 3.0 (Standard
Diagnostics, Inc., Korea) and Determine HIV-1/2 (Alere Medical,
Co., Ltd, Japan) tests. If the rapid tests were positive or discordant,
HIV infection was confirmed in the respective laboratories using
either third generation Murex HIV 1.2.O (Abbott UK, Dartford,
Kent, England) and Vironostika HIV Uniform II plus O
(bioMe´rieux Bv, The Netherlands) enzyme-linked immunosorbent
assays (ELISAs; microbicides-preparedness cohort), or only
Vironostika HIV Uniform II plus O ELISA (vaccines-prepared-
ness cohort). In the microbicides-preparedness cohort, samples
discrepant or indeterminate on ELISA were tested for P24
Antigen (Genetics Systems HIV-1 Ag EIA, Bio-rad Laboratories,
Marnes-la-Coquette, France) and if positive were classified as
HIV-positive. Samples negative for P24 antigen were tested by
Western Blot (INNO-LIA, HIV I/II score, Innogenetics NV,
Gent, Belgium). At enrolment and follow-up visits, HIV testing
was done using ELISAs as per the screening algorithm. In the
vaccines-preparedness cohort, the HIV testing algorithm used at
screening was applied at enrolment and throughout the follow-up
period.
In the microbicides-preparedness cohort, syphilis was deter-
mined by the Immutrep Rapid Plasma Reagin (RPR) card test
(Omega Diagnostics, Alva, Scotland) and the Treponema pallidum
particle hemagglutination assay (SERODIA TPPA, Fujirebio Inc.,
Tokyo, Japan). Previous syphilis infection was diagnosed if TPPA-
positive but RPR-negative, and active syphilis if TPPA–positive
and RPR-positive. Based on RPR titre, active syphilis was
categorised as low (,1:8) or high ($1:8) titre. Syphilis results
were not available for the vaccines-preparedness cohort. HSV-2
was detected using either type-specific IgG ELISA (Kalon
Biologicals Ltd., Guildford, UK; microbicides-preparedness co-
hort) or Herpes SelectTM 2 ELISA IgG assay (Focus Diagnostics,
Cypress, CA, USA; vaccines-preparedness cohort). Endocervical
swabs were collected for N. gonorrhoeae and C. trachomatis detection
by Amplicor PCR (Roche Diagnostics, Branchburg, NJ, USA). All
positive tests for N. gonorrhoeae were confirmed using specific
primers to the -16S DNA coding region in PCR in-house assays
(Sigma-Aldrich, UK) [13]. In the microbicides-preparedness
cohort, a vaginal swab was used to inoculate a culture (InPouch
TV, Biomed Diagnostics, San Jose, CA, USA), read by light
microscopy at 72 hours after incubation at 36–37uC, and a second
vaginal swab was rolled onto a slide, heat-affixed, gram-stained
and Nugent-scored for bacterial vaginosis [14]; these tests were not
performed in the vaccines-preparedness study. All laboratory tests
were performed at enrolment and every 3 months, except for N.
gonorrhoeae, C. trachomatis and T. vaginalis, which were measured at
enrolment and months 6 and 12 only.
Statistical Methods
Questionnaires were reviewed for completeness and consistency
at the research clinics and data were double-entered using
OpenClinica (Akaza Research, Waltham, MA, USA) or DMSys
software (SigmaSoft International, Chicago, IL, USA). Data were
analysed using Stata version 11 (StataCorp, College Station, TX,
USA).
Attendance rates by scheduled visit were determined as the
number of women who attended a visit divided by the number of
women enrolled. Rates of enrolment (among those screened) and
attendance (of those enrolled) were compared between the cohorts
using X2 tests.
Factors associated with HIV prevalence at screening, and HSV-
2 prevalence at enrolment, were examined using logistic regres-
sion. HIV and HSV-2 incidence during follow-up was calculated
among women who were negative for each infection at enrolment,
as the number of seroconversions divided by the total person-years
(PYRs) of observation. For each infection, the date of seroconver-
sion was assumed to be halfway between the last negative and first
positive results. Follow-up was included to the earliest of
seroconversion date or date last seen. The associations between
potential risk factors and seroconversion were summarised by
using incidence rate ratios (RR) from Poisson regression models.
Statistical significance of the models was assessed using likelihood-
ratio tests.
All models included age and town, considered a priori
confounders. For HIV prevalence at screening, age- and town-
adjusted factors which reached p,0.05 were included in a
multivariable model, and those with p.0.05 in the multivariable
analysis were removed. Finally, all the omitted covariates were
added back into the model and retained if p,0.05. The approach
to investigate potential determinants of HSV-2 prevalence at
enrolment, and HIV and HSV-2 incidence during follow-up,
followed similar principles, but within a three-level conceptual
framework since more-detailed data were collected at enrolment
and follow-up, compared to screening. Firstly, age- and town-
adjusted socio-demographic factors which reached p,0.05 were
included in a multivariable model; those remaining independently
associated at p,0.05 were retained in a core model. Secondly,
behavioural factors were added to this core model one by one;
those that were associated with the outcome at p,0.05, after
adjusting for socio-demographic factors, were included in a
multivariable model and retained if there remained evidence of
an association (p,0.05). Thirdly, biological factors were assessed
in a similar way. Lastly, all the omitted covariates were added back
into the model and retained if p,0.05. For all final models,
interactions were considered between covariates and town. Only
variables which were measured in both the microbicides- and
vaccines-preparedness studies were considered for inclusion in the
final multivariable models. Individuals with missing data for a
given variable were excluded from models which included that
variable. However, for time-dependent variables, if results were
not recorded at a given visit, either structurally (for infections not
measured at every visit) or due to missingness, then the last
observation was carried forward. Since some of the STIs are
curable, we also conducted a sensitivity analysis assuming that N.
gonorrhoeae, C. trachomatis and T. vaginalis were successfully treated
and therefore were negative at subsequent visits, unless there were
results to indicate otherwise.
Results
Screening and HIV Prevalence
Of 2,632 women screened, 669 (25%) were from Geita, 584
(22%) Kahama, 546 (21%) Shinyanga, and 833 (32%) Moshi.
Their median age and duration of working in their current facility
was 27 years (interquartile range, IQR: 22, 33) and 2 years (IQR:
1, 2), respectively. HIV status at screening was available for 2,229
(85%) women, of whom 358 were HIV-positive (16.1%; 95%
confidence interval, CI: 14.6, 17.6). The characteristics of all
women screened were broadly similar to those of the subset of
women with HIV results.
Factors Associated with HIV Prevalence at Screening
Most women (57%) with HIV results had completed primary
(but not reached secondary) education, were Christians (74%), had
HIV and HSV-2 among Tanzanian Women at High Risk
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one sexual partner in the last three months (62%) and were not
cohabiting with a male partner (67%). A substantial proportion of
women were separated or divorced or widowed (44%). In Table 1
we present the associations between HIV prevalence, socio-
demographic characteristics, and reported sexual behaviour.
In our final model, age, education, marital status, and type of
job were independently associated with HIV. Although the point
estimates indicated a slightly higher HIV prevalence in Kahama
(18.8%), Shinyanga (18.3%), and Moshi (14.5%) compared with
Geita (13.5%), there was no evidence of a difference overall
(p = 0.12). Compared with women aged ,20 years, HIV
prevalence was significantly higher among those aged 25–29
(aOR=3.06; 95% CI: 1.65, 5.68) and $30 years (aOR=4.61;
95% CI: 2.47, 8.60). The prevalence of HIV was also higher in
separated, divorced, or widowed (aOR=2.20; 95% CI: 1.56, 3.10)
and in single women (aOR=1.78; 95% CI: 1.18, 2.69) compared
with married women. HIV prevalence was lower among those
working as mamalishe (aOR=0.37; 95% CI: 0.24, 0.56) and other
employment (aOR=0.59; 95% CI: 0.45, 0.77) compared with
waitresses, and among women who had completed primary
(aOR=0.73; 95%CI: 0.56, 0.96) or reached secondary education
(aOR=0.34; 95% CI: 0.21, 0.54) compared with those with
incomplete primary education. There was no evidence of
interactions between town and job type (p = 0.42), education level
(p = 0.71) or marital status (p = 0.38).
Table 1. HIV prevalence at screening and associations with socio-demographic and sexual behaviour characteristics, among
women working in food and recreational facilities in northern Tanzania.
Factor N (column %) [1]
HIV prevalence,
row %
Town- and age-adjusted
OR (95% CI) [2]
Adjusted OR
(95% CI) [2,3]
Overall 2229 (100%) 16.10% – –
Town P= 0.04 P=0.12
Geita 639 (29%) 13.50% 1 (reference) 1 (reference)
Kahama 506 (23%) 18.80% 1.44 (1.04,1.99) 1.46 (1.05,2.04)
Shinyanga 520 (23%) 18.30% 1.18 (0.85,1.64) 1.33 (0.95,1.87)
Moshi 564 (25%) 14.50% 0.92 (0.66,1.28) 1.15 (0.80,1.66)
Type of job P,0.001 P,0.001
Waitress 1047 (47%) 19.60% 1 (reference) 1 (reference)
Mamalishe 312 (14%) 9.60% 0.32 (0.21,0.48) 0.37 (0.24,0.56)
Other staff 870 (39%) 14.10% 0.52 (0.40,0.67) 0.59 (0.45,0.77)
Age, years P,0.001 P,0.001
,20 200 (9%) 7.00% 1 (reference) 1 (reference)
20–24 676 (30%) 8.90% 1.30 (0.71,2.38) 1.23 (0.66,2.29)
25–29 539 (24%) 18.70% 3.06 (1.70,5.50) 3.06 (1.65,5.68)
$30 814 (37%) 22.50% 3.94 (2.22,6.98) 4.61 (2.47,8.60)
Highest formal education P,0.001 P,0.001
None/incomplete primary 608 (27%) 19.40% 1 (reference) 1 (reference)
Complete primary 1273 (57%) 16.90% 0.75 (0.58,0.98) 0.73 (0.56,0.96)
$Secondary 347 (16%) 7.20% 0.33 (0.21,0.52) 0.34 (0.21,0.54)
Religion P= 0.87 P = 0.88
Christian 1640 (74%) 16.20% 1 (reference) 1 (reference)
Muslim 573 (26%) 15.50% 0.95 (0.72,1.23) 0.95 (0.72,1.25)
None 13 (1%) 15.40% 1.29 (0.27,6.16) 0.75 (0.16,3.59)
Marital status P,0.001 P,0.001
Married 507 (23%) 10.30% 1 (reference) 1 (reference)
Separated/divorced/widowed 985 (44%) 22.50% 2.76 (1.98,3.86) 2.20 (1.56,3.10)
Single 736 (33%) 11.40% 2.01 (1.34,2.99) 1.78 (1.18,2.69)
N sex partners in last 3 months P= 0.004 P = 0.19
0 119 (5%) 14.30% 1 (reference) 1 (reference)
1 1362 (62%) 15.60% 1.21 (0.70,2.10) 1.31 (0.74,2.31)
2 380 (17%) 14.70% 1.30 (0.71,2.37) 1.06 (0.57,1.97)
$3 328 (15%) 21.30% 2.20 (1.21,4.01) 1.59 (0.85,2.98)
OR =odds ratio, CI = confidence interval. Includes only those women whose HIV status is known at screening (85% of cohort). [1] Numbers may not add up to total due
to missing data. [2] P-values from likelihood ratio test. The ORs for town are adjusted for age, and the ORs for age are adjusted for town. [3] Estimated ORs adjusted by
town, age, type of job, education and marital status (the adjusted results for these variables are shown in bold).
doi:10.1371/journal.pone.0068825.t001
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Enrolment and HSV-2 Prevalence
Of those screened, 1,242 (47%) women were not enrolled
(Figure 1). Women may have met .1 ineligibility criterion, with
the most common reasons being unlikely to comply with the
protocol (n = 431), lack of support from the facility manager
(n = 420), being HIV-positive (n = 419), not willing to attend
follow-up visits (n = 354) and working in the facility for less than 6
months (n = 341). Among 1,390 women enrolled, 12 were
excluded from this analysis due to incomplete baseline data.
Thus, 1,378 (966 (54% of those screened) microbicides-prepared-
ness cohort and 412 (49%) vaccines-preparedness cohort; p = 0.04)
women were included in this analysis. The characteristics of those
enrolled were similar to those screened for the study. At
enrolment, HSV-2 status was known for all but two women; 928
(67%) were HSV-2 positive (95% CI: 65, 70).
Factors Associated with HSV-2 Prevalence at Enrolment
In Table 2, we present the associations between socio-
demographic characteristics, sexual behaviour, biological factors
and HSV-2 prevalence at enrolment. In our final model, we
identified a number of independent predictors of HSV-2
prevalence. HSV-2 prevalence was lower in Moshi (52%,
aOR=0.45; 95% CI: 0.29, 0.71) and similar in other towns
(Kahama, 75%; Shinyanga, 76%) compared with Geita (73%).
HSV-2 prevalence was lower among women with secondary
education or higher (46%, aOR=0.53; 95% CI: 0.31, 0.88)
compared with those with incomplete primary education (78%);
and among women in other jobs besides mamalishe (64%,
aOR=0.67; 95% CI: 0.47, 0.95) compared with waitresses (67%).
HSV-2 prevalence increased from 40% among women aged
,20 years to 82% among those aged $30 years (aOR=8.73;
95% CI: 4.37, 17.5, comparing those aged $30 with ,20 years).
Compared to women with no problem drinking (65%) as
determined by the CAGE questionnaire, the HSV-2 prevalence
was higher among those with possible problem drinking (76%,
aOR=2.06; 95% CI: 1.30, 3.27), although there was no evidence
of a difference for those with probable problem drinking (75%,
aOR=0.93; 95%CI: 0.49, 1.79), perhaps due to small numbers of
women in this latter category. Women who initiated sexual activity
aged $16 years had lower HSV-2 prevalence (65%, aOR=0.64;
95% CI: 0.44, 0.95) compared with those who initiated aged ,16
years (74%). Other factors independently associated with higher
HSV-2 prevalence were higher number of lifetime sexual partners,
genital ulcers on examination, and having ever been pregnant.
There was no evidence of interactions between town and any of
these variables. Compared to those never infected, we observed
higher prevalence of HSV-2 among those with previous (95%,
aOR=4.32; 95% CI: 1.26, 14.9) or low-titre active syphilis
infection (98%, aOR=12.5; 95% CI: 1.49, 105), although there
was no evidence of a difference for those with high-titre active
infection (76%, aOR=0.83; 95% CI: 0.28, 2.44). Of note, these
results are from the microbicides-preparedness cohort only.
Follow-up and HIV and HSV-2 Incidence
Among 1,378 HIV-negative women in this analysis, attendance
at 3, 6, 9 and 12 month visits was 82%, 78%, 79% and 86%,
respectively (Figure 1). There were some differences in the
attendance between the microbicides- and vaccines-preparedness
cohorts, with 84% compared to 90%, respectively, attending the
12-month follow-up visit (p = 0.008). During the study period, with
over 1200 PYRs of follow-up, there were 44 HIV seroconversions,
yielding an overall HIV incidence of 3.7/100 PYRs (95% CI: 2.8,
5.1; Figure S1). Among 450 HSV-2-negative women and 339
PYRs of follow-up, we identified 97 HSV-2 seroconversions,
resulting in an overall HSV-2 incidence of 28.6/100 PYRs (95%
CI: 23.5, 35.0; Figure S1).
Factors Associated with HIV Acquisition during Follow-up
HIV incidence ranged from 2.4/100 PYRs in Shinyanga to
3.8/100 PYRs in Moshi and 4.3/100 PYRs in Geita and Kahama,
although there was no evidence of a difference by town (adjusted
p= 0.47; Table 3). While HIV incidence was higher among
younger women, there was no evidence of an age effect overall
(adjusted p= 0.52). In our final model, adjusted for town and age,
marital status and number of partners in last three months were
independently associated with HIV incidence. Women who were
separated, divorced, or widowed (adjusted incidence rate ratio
(aRR) = 6.63; 95% CI: 1.97, 22.2) and single women (aRR=2.93;
95% CI: 0.76, 11.3) were at higher HIV risk compared with those
married. Similarly, women reporting two partners (aRR=1.28;
95% CI: 0.48, 3.38) and $3 partners (aRR=4.75; 95% CI: 2.10,
10.8) in the past three months were at higher risk compared with
women with one or no partner. Due to low incidence, it was not
possible to reliably estimate interactions of these variables with
town. Of note, there was no evidence of an association between
HSV-2 status and HIV incidence (p = 0.33). The pre-specified
sensitivity analyses yielded point estimates substantially greater
than one, but the confidence intervals were large and therefore the
overall interpretations did not change (Table S1).
Factors Associated with HSV-2 Acquisition during Follow-
up
HSV-2 incidence ranged from 20.1/100 PYRs in Shinyanga to
32.6/100 PYRs in Moshi (Table 3). In our final model, there was
some evidence to suggest a difference by town, with those in Moshi
at highest HSV-2 risk, compared with Geita (aRR=1.55; 95% CI:
0.89, 2.69; global p = 0.07). Adjusted for town and age, education
and marital status were independently associated with HSV-2
incidence. Compared with women with incomplete primary
education, those who had completed primary education
(aRR=0.56; 95% CI: 0.33, 0.92) or reached secondary education
or above (aRR=0.38; 95% CI: 0.20, 0.72) were at lower HSV-2
risk. Women who were separated, divorced, or widowed
(aRR=1.97; 95% CI: 1.13, 3.42) and single women
(aRR=1.24; 95% CI: 0.68, 2.25) were at higher HSV-2 risk
compared with married women.
Discussion
In this study of women considered to be at increased risk of HIV
and other STIs in northern Tanzania, the prevalences of HIV and
HSV-2 were indeed high, at 16% and 67% respectively, indicating
that these infections continue to pose a major public health
problem in this population. While the prevalence of HIV was
somewhat lower than in earlier studies conducted in similar
cohorts [5,7,15–17], it remained higher than that reported among
women in the general population [3]. Women working in these
settings are known to be involved in complex sexual networks
including multiple partners and exchange of sex for gifts or money
[15,17]. The prevalence of HSV-2 and other STIs was compa-
rable to earlier studies conducted in these settings [5,15,17,18].
Thus, scaling-up of known effective interventions against HIV and
other STIs is a major priority in this population.
As expected, HIV and HSV-2 prevalence shared a number of
common risk factors including age, marital status, job type and
level of education. As observed in other studies [15,17–19], the
prevalence of HIV and HSV-2 infections was higher in older
participants, due to age being a proxy measure of the duration of
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Figure 1. Screening, enrolment and follow-up of two cohorts of women working in food and recreational facilities in northern
Tanzania. P-values are for the comparison in enrolment (of those screened) or attendance (of those enrolled) between the cohorts, by X2 test. [1]
Some women met more than one ineligibility criteria; all reasons given are reported, therefore the sum is greater than the number of women not
enrolled. [2] A window of +/21.5 months was allowed for each visit, except the month 12 visit where no upper bound was applied (maximum 23
months). Restricting the upper limit of the month 12 visit to 13.5, 15 or 18 months yielded attendance of 81%, 84% and 86%, respectively.
doi:10.1371/journal.pone.0068825.g001
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Table 2. HSV-2 seroprevalence at enrolment and associations with socio-demographic, sexual behaviour and biological
characteristics, among women working in food and recreational facilities in northern Tanzania.
Factor N (column %) [1]
HSV-2 prevalence,
row %
Town- and age-adjusted
OR (95% CI) [2]
Adjusted OR
(95% CI) [2,3]
Overall 1376 (100%) 67% – –
SOCIO-DEMOGRAPHIC FACTORS
Town P,0.001 P,0.001
Geita 375 (27%) 73% 1 (reference) 1 (reference)
Kahama 305 (22%) 75% 1.14 (0.79,1.64) 1.01 (0.62,1.66)
Shinyanga 284 (21%) 76% 0.91 (0.62,1.32) 0.98 (0.59,1.62)
Moshi 412 (30%) 52% 0.29 (0.21,0.40) 0.45 (0.29,0.71)
Type of job P= 0.02 P=0.02
Waitress 608 (44%) 67% 1 (reference) 1 (reference)
Mamalishe 204 (15%) 78% 1.02 (0.68,1.54) 1.20 (0.70,2.06)
Other staff 564 (41%) 64% 0.69 (0.53,0.91) 0.67 (0.47,0.95)
Age, years P,0.001 P,0.001
,20 105 (8%) 40% 1 (reference) 1 (reference)
20–24 431 (31%) 54% 2.17 (1.39,3.40) 2.22 (1.18,4.18)
25–29 344 (25%) 72% 4.92 (3.06,7.91) 4.75 (2.44,9.26)
$30 496 (36%) 82% 9.86 (6.11,15.9) 8.73 (4.37,17.5)
Highest formal education P,0.001 P=0.005
None/incomplete primary 337 (25%) 78% 1 (reference) 1 (reference)
Complete primary 810 (59%) 69% 0.65 (0.47,0.90) 1.04 (0.69,1.58)
$Secondary 228 (17%) 46% 0.33 (0.22,0.49) 0.53 (0.31,0.88)
Marital status P,0.001 P = 0.32
Married 356 (26%) 69% 1 (reference) 1 (reference)
Separated/divorced/widowed 579 (42%) 79% 1.62 (1.17,2.25) 1.29 (0.84,1.98)
Single 441 (32%) 51% 0.90 (0.64,1.28) 1.42 (0.88,2.29)
BEHAVIOURAL FACTORS
CAGE score [4] P,0.001 P=0.005
Non-drinker or no problem drinking 873 (76%) 65% 1 (reference) 1 (reference)
Possible problem drinking 184 (16%) 76% 2.05 (1.38,3.05) 2.06 (1.30,3.27)
Probable problem drinking 95 (8%) 75% 1.72 (1.01,2.93) 0.93 (0.49,1.79)
AUDIT score [5] P = 0.003 P = 0.91
Non-drinker or low-risk 1184 (86%) 66% 1 (reference) 1 (reference)
Harmful or hazardous drinking 185 (14%) 77% 1.77 (1.20,2.62) 1.04 (0.57,1.87)
Age at first sex, years P,0.001 P=0.02
,16 361 (28%) 74% 1 (reference) 1 (reference)
$16 915 (72%) 65% 0.60 (0.45,0.81) 0.64 (0.44,0.95)
N lifetime sex partners P,0.001 P=0.02
0–4 713 (61%) 59% 1 (reference) 1 (reference)
5–9 262 (23%) 72% 1.56 (1.11,2.20) 1.12 (0.75,1.67)
$10 189 (16%) 83% 2.70 (1.73,4.23) 2.13 (1.23,3.67)
N sex partners in last 12 months P= 0.005 P = 0.33
0–1 653 (50%) 64% 1 (reference) 1 (reference)
2 344 (27%) 70% 1.52 (1.10,2.09) 1.18 (0.77,1.80)
$3 301 (23%) 73% 1.66 (1.16,2.37) 0.79 (0.44,1.40)
N sex partners in last 3 months P= 0.007 P = 0.22
0 81 (6%) 63% 1 (reference) 1 (reference)
1 981 (72%) 66% 1.80 (1.06,3.05) 1.91 (0.97,3.77)
2 195 (14%) 74% 2.59 (1.40,4.78) 1.91 (0.83,4.39)
$3 104 (8%) 76% 2.82 (1.40,5.68) 1.33 (0.51,3.46)
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sexual activity and these being life-long infections. Women who
were separated, divorced, or widowed had the highest prevalence
of both infections. Such women may have been exposed to HIV in
their previous marriages and/or may engage with multiple sex
partners due to relative personal freedom and as they attempt to
establish new relationships. We also observed higher risk of HIV
and HSV-2 among waitresses compared with other type of jobs,
and lower risk associated with higher level of education. Level of
education has been associated with increased awareness about
STIs and use of protective devices such as condoms [20], although
we did not observe this in our study (data not shown). The
observed associations suggest that structural factors, such as the
level of education, may be important drivers of the infections in
this population.
Only limited data on potential behavioural risk factors were
collected during the screening visit, constraining our ability to
assess their associations with HIV prevalence. During enrolment,
and subsequent follow-up visits, a substantial proportion of women
Table 2. Cont.
Factor N (column %) [1]
HSV-2 prevalence,
row %
Town- and age-adjusted
OR (95% CI) [2]
Adjusted OR
(95% CI) [2,3]
Transactional sex in last year P= 0.05 P = 0.28
No 897 (65%) 65% 1 (reference) 1 (reference)
Yes 473 (35%) 73% 1.34 (1.00,1.80) 0.79 (0.51,1.21)
Contraception P= 0.03 P = 0.12
None of the following 526 (38%) 71% 1 (reference) 1 (reference)
Condoms only 433 (32%) 59% 0.75 (0.55,1.01) 0.66 (0.45,0.99)
Pill (+/2 condoms) 137 (10%) 74% 1.15 (0.73,1.80) 0.69 (0.39,1.21)
Injectable (DMPA; +/2 condoms) 221 (16%) 72% 1.20 (0.82,1.75) 1.15 (0.71,1.86)
Other hormonal contraceptives 56 (4%) 66% 0.97 (0.51,1.84) 0.70 (0.33,1.49)
BIOLOGICAL FACTORS
Ever pregnant P,0.001 P=0.001
No 208 (15%) 40% 1 (reference) 1 (reference)
Yes 1167 (85%) 72% 2.33 (1.63,3.33) 2.14 (1.35,3.40)
Syphilis [6] P,0.001 P,0.001
Negative 792 (82%) 71% 1 (reference) 1 (reference)
Previous infection 85 (9%) 95% 5.33 (1.90,15.0) 4.32 (1.26,14.9)
Active infection, low titre 41 (4%) 98% 16.1 (2.17,119) 12.5 (1.49,105)
Active infection, high titre 46 (5%) 76% 1.38 (0.66,2.86) 0.83 (0.28,2.44)
T. vaginalis [6] P = 0.20 P = 0.97
Negative 759 (80%) 74% 1 (reference) 1 (reference)
Positive 184 (20%) 76% 1.29 (0.87,1.92) 1.01 (0.59,1.73)
C. trachomatis P= 0.92 P = 0.67
Negative 1185 (88%) 68% 1 (reference) 1 (reference)
Positive 157 (12%) 62% 0.98 (0.67,1.43) 0.90 (0.56,1.45)
N. gonorrhoeae P= 0.11 P = 0.83
Negative 1290 (96%) 67% 1 (reference) 1 (reference)
Positive 51 (4%) 75% 1.71 (0.87,3.39) 1.10 (0.48,2.50)
Bacterial vaginosis [6] P = 0.005 P = 0.26
Negative 357 (37%) 71% 1 (reference) 1 (reference)
Indeterminate 160 (17%) 77% 1.69 (1.07,2.67) 1.37 (0.74,2.53)
Positive 446 (46%) 76% 1.69 (1.20,2.37) 1.47 (0.92,2.34)
Genital ulcers on examination P= 0.003 P=0.01
Negative 1249 (94%) 67% 1 (reference) 1 (reference)
Positive 84 (6%) 82% 2.39 (1.30,4.40) 2.50 (1.15,5.40)
OR=odds ratio, CI = confidence interval. Includes only those women whose HSV-2 status is known at enrolment (all but two). [1] Numbers may not add up to total due
to missing data. [2] P-values from likelihood ratio test. The ORs for town are adjusted for age, and the ORs for age are adjusted for town. [3] Estimated ORs adjusted by
town, age, job, education, CAGE category, age at first sex, number of partners in lifetime, genital ulcers on examination and ever pregnant (the adjusted results for these
variables are shown in bold). While there was strong evidence of an association between HSV-2 prevalence and syphilis, this factor was not included in the fully-adjusted
model, since it was only measured in the microbicides- and not the vaccines-preparedness cohort. [4] Based on responses to four CAGE questions. Score based on the
number of positive answers: 0–1 =non-drinker or no problem drinking, 2 = possible problem drinking, $3= probable problem drinking. [5] Based on responses to 10
AUDIT questions. Scores based on responses to each question: 0–7 non-drinker or low-risk, $8 harmful or hazardous drinking. [6] Results for syphilis, T. vaginalis
(diagnosed by 72-hour culture) and bacterial vaginosis (diagnosed by Nugent criteria) not available for vaccines-preparedness cohort.
doi:10.1371/journal.pone.0068825.t002
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Table 3. HIV and HSV-2 incidence and associations with socio-demographic, behavioural and biological factors, among women
working in food and recreational facilities in northern Tanzania.
HIV HSV-2 [1]
Factor
Cases/person-years
(rate per 100
person-years) [1]
Town- and age-
adjusted RR
(95% CI) [2]
Adjusted RR
(95% CI) [2,3]
Cases/person-years
(rate per 100
person-years) [1]
Town- and age-
adjusted RR
(95% CI) [2]
Adjusted RR
(95% CI) [2,4]
Overall 44/1200 (3.7) – – 97/339 (28.6)
SOCIO-DEMOGRAPHIC FACTORS AT ENROLMENT
Town P= 0.62 P=0.47 P= 0.39 P=0.07
Geita 13/305 (4.3) 1 (reference) 1 (reference) 20/69 (28.9) 1 (reference) 1 (reference)
Kahama 11/257 (4.3) 1.03 (0.46,2.30) 0.95 (0.42,2.15) 16/61 (26.1) 0.97 (0.50,1.88) 1.09 (0.56,2.13)
Shinyanga 6/249 (2.4) 0.57 (0.21,1.50) 0.68 (0.25,1.83) 11/55 (20.1) 0.70 (0.33,1.47) 0.69 (0.32,1.47)
Moshi 14/370 (3.8) 0.90 (0.42,1.92) 1.43 (0.65,3.17) 50/153 (32.6) 1.21 (0.71,2.06) 1.55 (0.89,2.69)
Type of job P= 0.10 P = 0.46 P = 0.92 P = 0.86
Waitress 24/501 (4.8) 1 (reference) 1 (reference) 41/150 (27.4) 1 (reference) 1 (reference)
Mamalishe 3/185 (1.6) 0.32 (0.09,1.07) 0.49 (0.14,1.70) 9/35 (25.7) 1.01 (0.47,2.19) 0.95 (0.43,2.10)
Other staff 17/494 (3.4) 0.70 (0.37,1.33) 0.97 (0.50,1.88) 47/154 (30.5) 1.09 (0.71,1.68) 1.11 (0.72,1.73)
Age, years P= 0.79 P=0.52 P= 0.45 P=0.35
,20 4/74 (5.4) 1.28 (0.43,3.81) 1.75 (0.53,5.76) 14/40 (35.2) 1.17 (0.59,2.29) 1.34 (0.63,2.88)
20–24 13/353 (3.7) 0.87 (0.42,1.79) 0.94 (0.43,2.06) 36/149 (24.2) 0.73 (0.44,1.23) 0.76 (0.43,1.32)
25–29 9/298 (3.0) 0.73 (0.33,1.63) 0.69 (0.30,1.56) 22/74 (29.9) 0.92 (0.52,1.65) 0.83 (0.46,1.51)
$30 18/455 (4.0) 1 (reference) 1 (reference) 25/76 (32.8) 1 (reference) 1 (reference)
Highest formal education P= 0.55 P = 0.55 P = 0.01 P=0.01
None/incomplete primary 10/276 (3.6) 1 (reference) 1 (reference) 23/49 (46.5) 1 (reference) 1 (reference)
Complete primary 29/707 (4.1) 1.17 (0.56,2.45) 1.40 (0.65,3.00) 54/192 (28.1) 0.55 (0.33,0.92) 0.56 (0.33,0.92)
$Secondary 5/197 (2.5) 0.71 (0.23,2.14) 0.96 (0.31,2.98) 19/96 (19.7) 0.38 (0.20,0.72) 0.38 (0.20,0.72)
Marital status P,0.001 P,0.001 P= 0.05 P=0.04
Married 3/325 (0.9) 1 (reference) 1 (reference) 22/90 (24.3) 1 (reference) 1 (reference)
Separated/divorced/widowed 30/492 (6.1) 7.25 (2.17,24.2) 6.63 (1.97,22.2) 35/87 (40.1) 1.82 (1.05,3.16) 1.97 (1.13,3.42)
Single 11/363 (3.0) 3.05 (0.79,11.7) 2.93 (0.76,11.3) 40/161 (24.9) 1.08 (0.60,1.95) 1.24 (0.68,2.25)
BEHAVIOURAL FACTORS AT ENROLMENT
Age at first sex, years P= 0.75 P = 0.96 P = 0.19 P = 0.49
,16 13/310 (4.2) 1 (reference) 1 (reference) 23/66 (34.9) 1 (reference) 1 (reference)
$16 29/784 (3.7) 0.89 (0.46,1.74) 1.02 (0.52,2.01) 66/249 (26.5) 0.72 (0.44,1.16) 0.84 (0.51,1.38)
TIME-VARYING BEHAVIOURAL FACTORS
N sex partners in last
3 months
P= 0.001 P=0.005 P= 0.21 P = 0.23
0–1 31/993 (3.1) 1 (reference) 1 (reference) 85/300 (28.3) 1 (reference) 1 (reference)
2 5/128 (3.9) 1.45 (0.55,3.82) 1.28 (0.48,3.38) 10/25 (40.0) 1.82 (0.93,3.57) 1.66 (0.84,3.26)
$3 8/56 (14.4) 6.04 (2.67,13.7) 4.75 (2.10,10.8) 2/13 (15.7) 0.68 (0.16,2.79) 0.55 (0.13,2.27)
Transactional sex in past 3 m P= 0.06 P = 0.83 P = 0.42 P = 0.73
No 33/969 (3.4) 1 (reference) 1 (reference) 85/291 (29.2) 1 (reference) 1 (reference)
Yes 11/209 (5.3) 2.08 (1.01,4.30) 1.10 (0.47,2.59) 12/46 (26.1) 1.31 (0.69,2.46) 1.12 (0.59,2.13)
Contraception P= 0.28 P = 0.24 P = 0.77 P = 0.82
None of the following 18/492 (3.7) 1 (reference) 1 (reference) 40/134 (29.8) 1 (reference) 1 (reference)
Condoms only 11/350 (3.1) 0.90 (0.42,1.91) 0.70 (0.32,1.51) 28/119 (23.6) 0.88 (0.54,1.44) 0.91 (0.55,1.50)
Pill (+/2 condoms) 4/115 (3.5) 0.75 (0.25,2.24) 0.68 (0.23,2.04) 9/26 (34.6) 1.03 (0.53,2.00) 1.11 (0.56,2.17)
Injectable (DMPA; +/2 condoms) 11/183 (6.0) 1.89 (0.88,4.08) 1.63 (0.75,3.52) 17/48 (35.1) 1.25 (0.69,2.24) 1.24 (0.68,2.25)
Other hormonal contraceptives 0/40 (0.0) [5] [5] 3/11 (28.5) [5] [5]
TIME-VARYING BIOLOGICAL FACTORS
HSV-2 status P= 0.15 P = 0.33
Negative 8/349 (2.3) 1 (reference) 1 (reference) – – –
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reported high-risk sexual behaviours. Earlier sexual debut and
higher number of lifetime sexual partners were associated with
HSV-2 prevalence. HSV-2 infection was also associated with
possible problem alcohol drinking based on the CAGE question-
naire. Alcohol consumption has been consistently related to risky
sexual behaviours, including multiple sex partners and lack of
condom use [21].
The HIV incidence observed in this study was comparable to
similar cohorts in Moshi and Mwanza, Tanzania, and South
Africa [4–6,19], but lower than that observed in another similar
cohort in Mbeya, Tanzania [22] and among women from the
general population in South Africa [23,24]. The HSV-2 incidence
was higher than that observed in similar cohorts in Moshi and
Mwanza [5,25], but comparable to Kenyan women with high-risk
sexual behaviour [26,27] and women attending sexual health
clinics in Alabama, US [28].
Both infections showed a trend toward increased acquisition
among women aged below 20, compared with over 30 years,
although the evidence was weak. Other studies have noted this
pattern of high HIV incidence among young women [4,24,29],
underscoring the vulnerability of young women to HIV and other
STIs. Similar patterns of associations for marital status and
education were observed for incidence as for prevalence. Of the
behavioural risk factors we examined, only the number of sex
partners during the past three months played a role, with a higher
number of partners independently associated with higher HIV
incidence. Although our models suffered from low power, in
general, associations with sexual behaviour variables were
relatively stronger for HIV than for HSV-2 infection. We did
not observe any associations between biological factors and either
HIV or HSV-2 incidence; this may be due to limited power or
perhaps curable STIs being diagnosed and treated and therefore
no longer present at the time of HIV infection.
A strength of this study is the inclusion of women from four
towns, across two cohort studies which were conducted in
comparable ways. Although this is a highly-mobile population,
we achieved a good retention rate of 86% over 12 months follow-
up. We explored a range of potential risk factors, covering socio-
Table 3. Cont.
HIV HSV-2 [1]
Factor
Cases/person-years
(rate per 100
person-years) [1]
Town- and age-
adjusted RR
(95% CI) [2]
Adjusted RR
(95% CI) [2,3]
Cases/person-years
(rate per 100
person-years) [1]
Town- and age-
adjusted RR
(95% CI) [2]
Adjusted RR
(95% CI) [2,4]
Positive (from baseline) 34/804 (4.2) 2.13 (0.94,4.81) 1.79 (0.77,4.12)
Positive (seroconverted during follow-
up)
1/26 (3.9) 1.11 (0.14,8.96) 0.95 (0.12,7.72)
Syphilis [6] P = 0.83 P = 0.57 P = 0.24 P = 0.16
Negative 26/661 (3.9) 1 (reference) 1 (reference) 43/172 (25.0) 1 (reference) 1 (reference)
Previous infection 2/77 (2.6) 0.73 (0.17,3.16) 0.72 (0.16,3.15) 3/5 (61.7) 2.49 (0.75,8.24) 1.59 (0.45,5.61)
Active infection 2/73 (2.7) 0.72 (0.17,3.06) 0.51 (0.12,2.20) 1/9 (11.4) 0.43 (0.06,3.13) 0.24 (0.03,1.85)
T. vaginalis infection [6] P = 0.58 P = 0.80 P = 0.30 P = 0.50
Negative 24/661 (3.6) 1 (reference) 1 (reference) 35/150 (23.4) 1 (reference) 1 (reference)
Positive 6/138 (4.4) 1.30 (0.53,3.19) 1.13 (0.46,2.78) 9/32 (28.1) 1.50 (0.71,3.17) 1.31 (0.61,2.85)
C. trachomatis infection P= 0.87 P = 0.71 P = 0.27 P = 0.52
Negative 41/1100 (3.9) 1 (reference) 1 (reference) 85/303 (28.1) 1 (reference) 1 (reference)
Positive 3/105 (2.9) 0.90 (0.28,2.96) 0.81 (0.24,2.65) 10/32 (30.9) 1.48 (0.76,2.87) 1.26 (0.64,2.50)
N. gonorrhoeae infection P= 0.37 P = 0.65 P = 0.86 P = 0.67
Negative 41/1100 (3.7) 1 (reference) 1 (reference) 92/325 (28.3) 1 (reference) 1 (reference)
Positive 3/44 (6.8) 1.80 (0.55,5.88) 1.33 (0.40,4.37) 3/10 (28.9) 0.90 (0.28,2.89) 0.79 (0.24,2.52)
Bacterial vaginosis infection [6] P = 0.32 P = 0.34 P = 0.24 P = 0.25
Negative 10/305 (3.3) 1 (reference) 1 (reference) 14/81 (17.4) 1 (reference) 1 (reference)
Indeterminate 3/149 (2.0) 0.58 (0.16,2.10) 0.48 (0.13,1.78) 10/32 (31.6) 1.76 (0.78,4.00) 1.60 (0.68,3.76)
Positive 17/357 (4.8) 1.34 (0.61,2.95) 1.11 (0.50,2.48) 23/73 (31.4) 1.68 (0.85,3.31) 1.74 (0.88,3.45)
Genital ulcers on examination P= 0.22 P = 0.29 P = 0.69 P = 0.75
Negative 40/1100 (3.6) 1 (reference) 1 (reference) 91/325 (28.0) 1 (reference) 1 (reference)
Positive 4/58 (6.9) 2.03 (0.72,5.74) 1.85 (0.65,5.26) 3/9 (31.9) 1.28 (0.40,4.08) 1.21 (0.38,3.89)
HIV P= 0.42 P = 0.37
Negative – – – 95/336 (28.3) 1 (reference) 1 (reference)
Positive 2/2 (81.0) 1.92 (0.46,8.11) 2.07 (0.49,8.74)
RR = incidence rate ratio, CI = confidence interval. [1] Numbers may not add up to total due to missing data. [2] P-values from likelihood ratio test. The ORs for town are
adjusted for age, and the ORs for age are adjusted for town. [3] Estimated RRs adjusted for town, age, marital status and time-updated number of partners in last 3
months (the adjusted results for these variables are shown in bold). [4] Estimated RRs adjusted for town, age, education and marital status (the adjusted results for these
variables are shown in bold). [5] Other hormonal contraceptives grouped with pill, due to low numbers. [6] Results for syphilis, T. vaginalis (diagnosed by 72-hour
culture) and bacterial vaginosis (diagnosed by Nugent criteria) not available for vaccines-preparedness cohort.
doi:10.1371/journal.pone.0068825.t003
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demographic, sexual, and other behaviour and clinical variables,
although self-reported behavioural factors are likely to suffer from
social desirability and recall bias.
While the two cohort studies were conducted in very similar
ways, there were some differences in the laboratory methods
applied. HIV confirmatory testing algorithms and HSV-2 test kits
differed between the two cohorts, and the two HSV-2 assays used
are known to have different performance in African settings [30].
Syphilis results were not available for the vaccines-preparedness
cohort. While bacterial vaginosis and T. vaginalis were diagnosed
by Amsel clinical criteria [31] and wet mount, respectively, in the
vaccines-preparedness cohort, we used only the results from the
microbicides-preparedness cohort, where these infections were
diagnosed by gold standard methods (Nugent criteria [32] and 72-
hour culture [33], respectively). An implication of these differences
is that we had reduced power to assess the associations of HIV and
HSV-2 infection with factors that were only measured in one
cohort. We also had limited power to investigate interactions of
risk factors with town. Further, there was some evidence of better
retention in the vaccines-preparedness cohort, perhaps due to this
study team having worked in Moshi town with similar cohorts in a
number of previous studies [6,15], and/or greater mobility among
the women enrolled in the microbicides-preparedness cohort (data
not shown).
In summary, these results confirm that women working in
hotels, bars and other food and recreational facilities in northern
Tanzania continue to be at increased risk of both HIV and HSV-2
infections, and may be one of the core groups playing an
important role in the continued transmission of HIV. Identifica-
tion of core groups in countries such as Tanzania, where the HIV
epidemic is generalised, is an important initial step before the
design of targeted HIV prevention interventions. We identified a
number of demographic characteristics, including age, marital
status, level of education, and reported sexual behaviours, which
were independently associated with increased risk of infections in
this population. This knowledge may be used to identify women at
highest risk of HIV infection for inclusion in future HIV
prevention trials or to design interventions that address the
individual and structural drivers of the epidemic. Development
and testing of new promising interventions among the most
affected populations in rigorously conducted clinical trials remain
a major priority for Africa. Although recruiting and retaining
participants at highest risk of HIV in clinical trials may be difficult
[5], we have demonstrated the feasibility of undertaking such trials
in highly-mobile populations, with the possibility of maintaining
high retention rates during the follow-up period.
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